Evaluation of Exparel Adductor Canal Field Block for Pain Control After ACL Reconstruction

Status unconfirmed · Phase 3

Conditions studied: Anterior Cruciate Ligament Tear, Pain, Postoperative, Opioid Use

In brief

This is a prospective, randomized study for adult patients presenting to the Carilion Clinic Institute of Orthopedics and Neurosurgery. Patients undergoing isolated ACL reconstruction will be eligible for inclusion. All patients will receive an adductor canal block (either with bupivacaine or Exparel. Patients will be given a pain diary for self-report of pill counts, pain scores, block duration, and pain control satisfaction). Pill counts and pain scores will also be taken by a team member at two and six-week post-operative visits. Primary outcomes include opioid requirements and pain scores.

Key facts

Study ID

NCT04764916

Run by

Carilion Clinic

People needed

60

Starts

2021-02-16

Expected to finish

2022-03-02

Last updated by the study team

2021-02-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-65 years old
• Presenting to Carilion Clinic Institute of Orthopedics and Neuroscience
• Receiving an isolated, first-time ACL reconstruction
• Operation to be performed at the Roanoke Ambulatory Surgery Center

You may not qualify if…

• Prior opioid use within 30 days of operation
• Under 18 or over 65 years old
• Use of opioids for chronic pain management
• Patients with multi-ligament injuries
• Patients who are receiving a revision of a previously reconstructed ACL
• Patients with an allergy to the study drug(s)
• Patients not medically eligible for surgery
• Women who are pregnant

Where it is running

• Carilion Clinic Institute for Orthopaedics and Neurosciences — Roanoke, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.